UnicoCell (6794) Monthly Revenue

Market: TWSE-listed · Industry: Biotech & Medical · 向榮生技

UnicoCell (6794) reported revenue of NT$1.3 million for Oct 2026, -44.4% year on year and -48.7% from the previous month. Revenue for Jan–Oct 2026 was NT$18.6 million (-28.5% year on year).

In Oct 2026, it ranked No. 148 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$2.6 million24/10Nov 2024 NT$2.2 millionDec 2024 NT$6.1 millionJan 2025 NT$3.4 millionFeb 2025 NT$919,00025/02Mar 2025 NT$5.6 millionApr 2025 NT$5.5 millionMay 2025 NT$935,000Jun 2025 NT$2.2 million25/06Jul 2025 NT$3 millionAug 2025 NT$883,000Sep 2025 NT$1.4 millionOct 2025 NT$2.3 million25/10Nov 2025 NT$1.9 millionDec 2025 NT$2.1 millionJan 2026 NT$1.8 millionFeb 2026 NT$2.6 million26/02Mar 2026 NT$1.9 millionApr 2026 NT$1.9 millionMay 2026 NT$1.4 millionJun 2026 NT$1.3 million26/06Jul 2026 NT$2.4 millionAug 2026 NT$1.5 millionSep 2026 NT$2.5 millionOct 2026 NT$1.3 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$1.3 million-44.4%-48.7%
Sep 2026NT$2.5 million+83.7%+62.6%
Aug 2026NT$1.5 million+74.4%-36.5%
Jul 2026NT$2.4 million-18.8%+90.0%
Jun 2026NT$1.3 million-43.0%-10.5%
May 2026NT$1.4 million+52.4%-24.8%
Apr 2026NT$1.9 million-65.5%+1.3%
Mar 2026NT$1.9 million-66.4%-28.9%
Feb 2026NT$2.6 million+186.2%+47.8%
Jan 2026NT$1.8 million-47.2%-15.4%
Dec 2025NT$2.1 million-65.2%+8.4%
Nov 2025NT$1.9 million-10.1%-16.0%
Oct 2025NT$2.3 million-11.8%+69.5%
Sep 2025NT$1.4 million-76.9%+54.4%
Aug 2025NT$883,000-85.7%-70.4%
Jul 2025NT$3 million+14.8%+33.3%
Jun 2025NT$2.2 million+25.6%+139.6%
May 2025NT$935,000+90.4%-83.0%
Apr 2025NT$5.5 million+284.2%-1.1%
Mar 2025NT$5.6 million+1,095.1%+504.7%
Feb 2025NT$919,000+170.3%-72.7%
Jan 2025NT$3.4 million+81.0%-44.3%
Dec 2024NT$6.1 million+24.0%+180.2%
Nov 2024NT$2.2 million+1.2%-17.6%
Oct 2024NT$2.6 million+158.1%-55.5%

Jan–Oct 2026 cumulative: NT$18.6 million (-28.5% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: UnicoCell vs PEC / UnicoCell vs Lotus Pharm / UnicoCell vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16